Prices and Value Not Well Aligned for Common CV Drugs in US Prices and Value Not Well Aligned for Common CV Drugs in US

In a modeling study estimating the incremental cost-effectiveness ratios for 30 commonly used cardiovascular (CV) drugs, there was little indication that prices are influenced by health benefits.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news